Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Regeneron and Sanofi have expanded their antibody alliance to co-develop four long-acting immunology antibodies. Regeneron will receive a $1 billion upfront payment and up to $7 billion in potential milestones, with costs and profits to be shared 50:50 globally.
Regeneron Pharmaceuticals (REGN) has expanded its antibody collaboration with Sanofi, adding four long-acting immunology antibodies. Regeneron will receive $1 billion upfront and could receive up to $7 billion in milestones. The companies will share costs and split future profits 50:50 globally.